13D Filing: VenBio Select Advisor and Immunomedics Inc (IMMU)

Page 6 of 7 – SEC Filing

SIGNATURES

After reasonable inquiry and to the best
of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date: November 15, 2017

venBio Select Advisor LLC
/s/ Scott Epstein
Name: Scott Epstein
Title: Chief Financial Officer
& Chief Compliance Officer
/s/ Behzad Aghazadeh
BEHZAD AGHAZADEH

Follow Immunomedics Inc (NASDAQ:IMMU)